Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aggp11
    Member
    • Jun 2011
    • 87

    #1

    DESeq2 for targeted RNA-Seq

    Hi,

    We plan to run some targeted whole transcriptome rna-seq using the AmpliSeq RNA methodology currently being sold by Life Technologies/Thermo Fisher. As a background on the technique, LT has designed 100-200bp probes for >20,800 features from RefSeq and provide that as a tool to study gene level differential expression. You can find more information here:



    I have been using DESeq2 for our whole transcriptome sequencing data and am wondering if DESeq2 will work for this targeted approach. I am reading/trying to understand more about the Math behind DESeq2 and on the surface it seems that DESeq2 should work fine because if I understand it correctly,"gene length" doesn't necessarily factor in the sizefactor based feature level normalization (unlike RPKM/FPKM, which in this case can be replaced by RPM/FPM). However, I am curious to know if I am overlooking something that might affect how DESeq2 would behave for such an experimental design.

    I'll appreciate any insights on this.

    Thank you!
  • Wolfgang Huber
    Senior Member
    • Aug 2009
    • 109

    #2
    Dear AGGP11,

    there is no fundamental reason why DESeq2 should not work with data from such an approach. As you say, the crucial assumption is that the number of reads for a gene is (to good enough approximation) proportional to its abundance, and that the proportionality factor -whatever it is- does not change between samples. So I'd make some exploratory plots to check whether this seems to be true for the data at hand.

    Wolfgang
    Wolfgang Huber
    EMBL

    Comment

    • aggp11
      Member
      • Jun 2011
      • 87

      #3
      Dear Wolfgang,

      Thank you for the response.

      Praful

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      39 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...